Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Carcinoma × Sorafenib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 6 OTHER 3 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 3 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Neoplasms 1 Liver Neoplasms 1 Carcinoma 1

Interventions

Sorafenib 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01214343 2011-06-15

Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC

Ministry of Health, Labour and Welfare, Japan

Phase 3 Unknown

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡